12.
Slieker, R. C., Donnelly, L. A., Lopez-Noriega, L., Muniangi-Muhitu, H., Akalestou, E., Sheikh, M., Georgiadou, E., Giordano, G. N., Åkerlund, M., Ahlqvist, E., Ali, A., Barovic, M., Bouland, G. A., Burdet, F., Canouil, M., Dragan, I., Elders, P. J., Fernandez, C., Festa, A., Fitipaldi, H., Froguel, P., Gudmundsdottir, V., Gudnason, V., Gerl, M. J., van der Heijden, A. A., Jennings, L. L., Hansen, M. K., Kim, M., Leclerc, I., Klose, C., Kuznetsov, D., Aly, D. M., Mehl, F., Marek, D., Melander, O., Niknejad, A., Ottosson, F., Pavo, I., Efanov, A., Duffin, K., Pullen, T. J., Simons, K., Solimena, M., Suvitaival, T., Wretlind, A., Rossing, P., Lyssenko, V., Quigley, C. L., Groop, L., Thorens, B., Franks, P. W., Ibberson, M., Beulens, J. W., ’t Hart, L. M., Pearson, E. R. & Rutter, G. A.
Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study.
(Endocrinology (including Diabetes Mellitus and Metabolic Disease), 2021).
http://medrxiv.org/lookup/doi/10.1101/2021.04.22.21255625.